zeranol has been researched along with Osteoporosis, Postmenopausal in 1 studies
*Osteoporosis, Postmenopausal: Metabolic disorder associated with fractures of the femoral neck, vertebrae, and distal forearm. It occurs commonly in women within 15-20 years after menopause, and is caused by factors associated with menopause including estrogen deficiency. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bryant, HU; Dodge, JA; Grese, TA; Sato, M; Turner, CH | 1 |
1 review(s) available for zeranol and Osteoporosis, Postmenopausal
| Article | Year |
|---|---|
Emerging therapies for the prevention or treatment of postmenopausal osteoporosis.
Topics: Animals; Bone Density; Bone Resorption; Estrogen Replacement Therapy; Exercise; Female; Humans; Osteoporosis, Postmenopausal; Receptors, Estrogen | 1999 |